252 related articles for article (PubMed ID: 33958886)
41. Efficacy and tolerability of low molecular weight hyaluronic acid sodium salt 0.2% cream in rosacea.
Schlesinger TE; Powell CR
J Drugs Dermatol; 2013 Jun; 12(6):664-7. PubMed ID: 23839183
[TBL] [Abstract][Full Text] [Related]
42. Characterization of rosacea in Chinese: An analysis of 254 cases.
Chang J; Wang Y; Sun D; Zhang L; Man MQ; Tu Y; Jiang X; He L; Gu H
J Cosmet Dermatol; 2021 Nov; 20(11):3666-3671. PubMed ID: 33655687
[TBL] [Abstract][Full Text] [Related]
43. Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.
Thiboutot D; Anderson R; Cook-Bolden F; Draelos Z; Gallo RL; Granstein RD; Kang S; Macsai M; Gold LS; Tan J
J Am Acad Dermatol; 2020 Jun; 82(6):1501-1510. PubMed ID: 32035944
[TBL] [Abstract][Full Text] [Related]
44. Rosacea: Diagnosis and Treatment.
Oge' LK; Muncie HL; Phillips-Savoy AR
Am Fam Physician; 2015 Aug; 92(3):187-96. PubMed ID: 26280139
[TBL] [Abstract][Full Text] [Related]
45. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis.
Jørgensen AR; Egeberg A; Gideonsson R; Weinstock LB; Thyssen EP; Thyssen JP
J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2010-2015. PubMed ID: 28543746
[TBL] [Abstract][Full Text] [Related]
46. Treatment options for acne rosacea.
Goldgar C; Keahey DJ; Houchins J
Am Fam Physician; 2009 Sep; 80(5):461-8. PubMed ID: 19725487
[TBL] [Abstract][Full Text] [Related]
47. Potential Role of Tranexamic Acid in Rosacea Treatment: conquering Flushing Beyond Melasma.
Zhang J; Gu D; Yan Y; Pan R; Zhong H; Zhang C; Xu Y
Clin Cosmet Investig Dermatol; 2024; 17():1405-1412. PubMed ID: 38895607
[TBL] [Abstract][Full Text] [Related]
48. Association between rosacea and smoking: A systematic review and meta-analysis.
Yuan X; Yin D
Dermatol Ther; 2021 Mar; 34(2):e14747. PubMed ID: 33406295
[TBL] [Abstract][Full Text] [Related]
49. The safety and efficacy of botulinum toxin for management of scars: A systematic review with meta-analysis and trial sequential analysis.
Wang D; Qu J; Jiang H; Jiang Y
Toxicon; 2019 Aug; 166():24-33. PubMed ID: 31047933
[TBL] [Abstract][Full Text] [Related]
50. Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review.
van Zuuren EJ; Kramer SF; Carter BR; Graber MA; Fedorowicz Z
Br J Dermatol; 2011 Oct; 165(4):760-81. PubMed ID: 21692773
[TBL] [Abstract][Full Text] [Related]
51. Rationale for Use of Combination Therapy in Rosacea.
Stein Gold L; Baldwin H; Harper JC
J Drugs Dermatol; 2020 Oct; 19(10):929-934. PubMed ID: 33026776
[TBL] [Abstract][Full Text] [Related]
52. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials.
Farag SM; Mohammed MO; El-Sobky TA; ElKadery NA; ElZohiery AK
JBJS Rev; 2020 Mar; 8(3):e0119. PubMed ID: 32224633
[TBL] [Abstract][Full Text] [Related]
53. Noninvasive objective skin measurement methods for rosacea assessment: a systematic review.
Logger JGM; de Vries FMC; van Erp PEJ; de Jong EMGJ; Peppelman M; Driessen RJB
Br J Dermatol; 2020 Jan; 182(1):55-66. PubMed ID: 31120136
[TBL] [Abstract][Full Text] [Related]
54. Rosacea: An Update in Diagnosis, Classification and Management.
Kang CN; Shah M; Tan J
Skin Therapy Lett; 2021 Jul; 26(4):1-8. PubMed ID: 34347259
[TBL] [Abstract][Full Text] [Related]
55. Botulinum toxin for myofascial pain syndromes in adults.
Soares A; Andriolo RB; Atallah AN; da Silva EM
Cochrane Database Syst Rev; 2012 Apr; (4):CD007533. PubMed ID: 22513950
[TBL] [Abstract][Full Text] [Related]
56. Assessment of rosacea severity: A review of evaluation methods used in clinical trials.
Hopkinson D; Moradi Tuchayi S; Alinia H; Feldman SR
J Am Acad Dermatol; 2015 Jul; 73(1):138-143.e4. PubMed ID: 25799418
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of botulinum toxin type A in distraction osteogenesis of the lower extremities: a meta-analysis of randomized controlled trials.
Su YC; Guo YH; Hsieh PC; Lin YC
BMC Musculoskelet Disord; 2022 Mar; 23(1):286. PubMed ID: 35337325
[TBL] [Abstract][Full Text] [Related]
58. Subjective and Objective Measurements of the Facial Effects of Microdoses of Botulinum Toxin.
Hexsel D; Valente-Bezerra I; Mosena G; Oakim Mourao MA; Fabris VC
Dermatol Pract Concept; 2023 Jul; 13(3):. PubMed ID: 37557136
[TBL] [Abstract][Full Text] [Related]
59. Alcohol consumption and the risk of rosacea: A systematic review and meta-analysis.
Liu L; Xue Y; Chen Y; Pu Y; Zhang Y; Zhang L; Shao X; Chen J; Chen J
J Cosmet Dermatol; 2022 Jul; 21(7):2954-2961. PubMed ID: 34582097
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
